Leslie H. Brail

eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch et al. · Cancer Research · 2009 · 197 citations

Eif4e Activation, Urology, Genitourinary Cancer +11

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

David A. Rizzieri, Sarah Cooley, Olatoyosi Odenike et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 74 citations

Gene expression in individual cells: analysis using global single cell reverse transcription polymerase chain reaction (GSC RT-PCR)

Leslie H. Brail, Anne Jang, Filio Billia et al. · Mutation Research/Mutation Research Genomics · 1999 · 49 citations

Polymerase Chain Reaction, Gsc Rt-pcr, Individual Cells +10

Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer

Pasi A. Jänne, Luis Paz‐Ares, Yun Oh et al. · Journal of Thoracic Oncology · 2013 · 34 citations

Oncology, Ltb4 Antagonist Ly293111, Pharmacology +5

A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours

Tara Baetz, Elizabeth A. Eisenhauer, Lillian L. Siu et al. · Investigational New Drugs · 2006 · 30 citations

Oncology, Medicine, Solid Tumours +9